The diminished expression of TRPV1 and TRPV4 in cancer-bearing animals does not represent a poorly executed function but rather an interconnection between the receptor’s continuous activation by the distant invasive tumor and the increased nociception afterward. The gene discussed is TRPV1; the disease is neoplasm.